Shuta Tomida

Title: Shuta Tomida: Innovator in Cancer Research

Introduction

Shuta Tomida is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of cancer research through his innovative work on antibodies. His research focuses on developing effective treatments for cancer metastasis and inflammatory diseases.

Latest Patents

Shuta Tomida holds a patent for an "Anti-S100A8/A9 antibody and use thereof." This invention provides a substance capable of effectively suppressing cancer metastasis or a pharmaceutical composition that acts on inflammatory diseases. The pharmaceutical composition contains an antibody or an antibody fragment that has antigen-binding activity for the S100A8/A9 heterodimer. This invention blocks the interaction between S100A8/A9 and its receptors, thereby strongly suppressing cancer metastasis both in vitro and in vivo, or alleviating inflammation. The anti-S100A8/A9 antibody or its fragment can significantly impact cancer treatment and inflammatory conditions.

Career Highlights

Shuta Tomida has worked at prestigious institutions such as Okayama University and Niigata University. His research has been pivotal in advancing the understanding of cancer biology and therapeutic interventions.

Collaborations

Shuta has collaborated with notable colleagues, including Masakiyo Sakaguchi and Shinichi Toyooka. These collaborations have further enriched his research and contributed to the development of innovative solutions in cancer treatment.

Conclusion

Shuta Tomida's work exemplifies the impact of innovative research in the medical field, particularly in cancer treatment. His contributions through patents and collaborations highlight the importance of scientific advancements in improving health outcomes.